S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
My No. 1 dividend stock for a LIFETIME of income. (Ad)
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Closing prices for crude oil, gold and other commodities
Fed's Shocking New Plan to Control Your Money (Ad)
Dividend King Genuine Parts Company Upgraded On Profit Guidance
11 Best Consumer Discretionary Stocks of 2023
Fed's Shocking New Plan to Control Your Money (Ad)
The Bottom Is In For Accenture
14 Best Consumer Staples Dividend Stocks
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
My No. 1 dividend stock for a LIFETIME of income. (Ad)
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Closing prices for crude oil, gold and other commodities
Fed's Shocking New Plan to Control Your Money (Ad)
Dividend King Genuine Parts Company Upgraded On Profit Guidance
11 Best Consumer Discretionary Stocks of 2023
Fed's Shocking New Plan to Control Your Money (Ad)
The Bottom Is In For Accenture
14 Best Consumer Staples Dividend Stocks
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
My No. 1 dividend stock for a LIFETIME of income. (Ad)
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Closing prices for crude oil, gold and other commodities
Fed's Shocking New Plan to Control Your Money (Ad)
Dividend King Genuine Parts Company Upgraded On Profit Guidance
11 Best Consumer Discretionary Stocks of 2023
Fed's Shocking New Plan to Control Your Money (Ad)
The Bottom Is In For Accenture
14 Best Consumer Staples Dividend Stocks
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
My No. 1 dividend stock for a LIFETIME of income. (Ad)
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Closing prices for crude oil, gold and other commodities
Fed's Shocking New Plan to Control Your Money (Ad)
Dividend King Genuine Parts Company Upgraded On Profit Guidance
11 Best Consumer Discretionary Stocks of 2023
Fed's Shocking New Plan to Control Your Money (Ad)
The Bottom Is In For Accenture
14 Best Consumer Staples Dividend Stocks
NASDAQ:ADMP

Adamis Pharmaceuticals - ADMP Stock Forecast, Price & News

$0.12
0.00 (0.00%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.11
▼
$0.12
50-Day Range
$0.10
▼
$0.30
52-Week Range
$0.10
▼
$0.62
Volume
553,541 shs
Average Volume
1.36 million shs
Market Capitalization
$17.85 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

ADMP stock logo

About Adamis Pharmaceuticals (NASDAQ:ADMP) Stock

Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development, and sale of pharmaceutical, specialty biopharmaceutical, and other drug products. The company provides products in various therapeutic areas, including allergy, respiratory, opioid overdose, and erectile dysfunction markets. It offers the SYMJEPI Injection for the emergency treatment of allergic reactions. The company was founded in June 2006 and is headquartered in San Diego, CA.

Receive ADMP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Adamis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ADMP Stock News Headlines

March 21, 2023 | americanbankingnews.com
StockNews.com Begins Coverage on Adamis Pharmaceuticals (NASDAQ:ADMP)
March 20, 2023 | americanbankingnews.com
Adamis Pharmaceuticals (NASDAQ:ADMP) Coverage Initiated at StockNews.com
March 25, 2023 | Weiss Ratings (Ad)
Bank Accounts: Frozen!
In 1990, the Brazilian government froze the bank accounts of thousands of citizens. In 2013, the victims were the people of Cyprus. In 2022, it hit closer to home — in Canada. And now the Federal Reserve System Docket No. OP-1670 reveals the plan to give the Fed the power to track and potentially even control your checking account. Not just the money you have in your account … But also, every single check, withdrawal, deposit and transaction. Practically everything you do with your money!
March 19, 2023 | finance.yahoo.com
Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Q4 2022 Earnings Call Transcript
March 17, 2023 | finance.yahoo.com
Q4 2022 Adamis Pharmaceuticals Corp Earnings Call
March 16, 2023 | msn.com
Adamis Pharmaceuticals GAAP EPS of -$0.18, revenue of $4.75M
March 16, 2023 | finance.yahoo.com
Adamis Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Corporate Update
March 14, 2023 | finance.yahoo.com
Adamis Pharmaceuticals Schedules Fourth Quarter and Full Year 2022 Financial Results Conference Call and Corporate Update
March 25, 2023 | Weiss Ratings (Ad)
Bank Accounts: Frozen!
In 1990, the Brazilian government froze the bank accounts of thousands of citizens. In 2013, the victims were the people of Cyprus. In 2022, it hit closer to home — in Canada. And now the Federal Reserve System Docket No. OP-1670 reveals the plan to give the Fed the power to track and potentially even control your checking account. Not just the money you have in your account … But also, every single check, withdrawal, deposit and transaction. Practically everything you do with your money!
March 14, 2023 | finance.yahoo.com
Adamis Pharmaceuticals Announces $3.0 Million Registered Direct Offering
March 2, 2023 | benzinga.com
Short Volatility Alert: Adamis Pharmaceuticals
March 1, 2023 | benzinga.com
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Adamis Pharmaceuticals Corporation Merger
February 28, 2023 | msn.com
Opioid Focused Adamis Pharma Agrees To Merge With Privately Held DMK Pharmaceuticals
February 28, 2023 | msn.com
Adamis Pharmaceuticals jumps 36% on DMK Pharmaceuticals merger plan
February 27, 2023 | finance.yahoo.com
Adamis Pharmaceuticals and DMK Pharmaceuticals Announce Agreement and Plan of Merger
February 22, 2023 | finance.yahoo.com
Nasdaq Grants Adamis Pharmaceuticals’ Request for Extension to Comply with Continued Listing Requirements
December 29, 2022 | finance.yahoo.com
Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Q3 2022 Earnings Call Transcript
November 15, 2022 | finanznachrichten.de
Adamis Pharmaceuticals Corporation: Adamis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 15, 2022 | seekingalpha.com
Adamis Pharmaceuticals Corporation (ADMP) Q3 2022 Earnings Call Transcript
November 15, 2022 | finance.yahoo.com
Adamis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 12, 2022 | msn.com
A Preview Of Adamis Pharmaceuticals's Earnings
November 7, 2022 | finance.yahoo.com
Adamis Pharmaceuticals Schedules Third Quarter 2022 Financial Results Conference Call and Corporate Update
October 18, 2022 | msn.com
Why fuboTV Shares Are Trading Higher By 11%; Here Are 22 Stocks Moving Premarket
October 12, 2022 | msn.com
Why Cango Shares Are Trading Higher; Here Are 27 Stocks Moving Premarket
October 5, 2022 | marketwatch.com
Adamis Pharmaceuticals Shares Jump 14% On Potential Sale, Strategic Alternatives
October 3, 2022 | nasdaq.com
Adamis Pharma To Explore Strategic Alternatives; Stock Up 10%
October 3, 2022 | finance.yahoo.com
Adamis Announces Review of Strategic Alternatives
See More Headlines
Receive ADMP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Adamis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ADMP Company Calendar

Last Earnings
3/31/2022
Today
3/24/2023
Next Earnings (Estimated)
5/15/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ADMP
CUSIP
N/A
CIK
887247
Web
www.adamispharmaceuticals.com
Phone
(858) 997-2400
Fax
N/A
Employees
116
Year Founded
2006

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-26,480,000.00
Net Margins
-556.71%
Pretax Margin
-550.82%
Return on Equity
-420.53%
Return on Assets
-147.30%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.81
Quick Ratio
0.70

Sales & Book Value

Annual Sales
$4.76 million
Price / Sales
3.75
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.01) per share
Price / Book
-11.90

Miscellaneous

Outstanding Shares
149,980,000
Free Float
148,033,000
Market Cap
$17.85 million
Optionable
Optionable
Beta
1.26

Social Links


Key Executives

  • David J. Marguglio
    President, Chief Executive Officer & Director
  • David C. Benedicto
    Chief Financial & Accounting Officer
  • Thomas H. Moll
    Vice President-Research

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions













ADMP Stock - Frequently Asked Questions

How have ADMP shares performed in 2023?

Adamis Pharmaceuticals' stock was trading at $0.1693 at the beginning of 2023. Since then, ADMP shares have decreased by 29.7% and is now trading at $0.1190.
View the best growth stocks for 2023 here.

When is Adamis Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 15th 2023.
View our ADMP earnings forecast.

How were Adamis Pharmaceuticals' earnings last quarter?

Adamis Pharmaceuticals Co. (NASDAQ:ADMP) announced its earnings results on Thursday, March, 31st. The specialty pharmaceutical company reported ($0.06) EPS for the quarter, missing the consensus estimate of ($0.04) by $0.02. Adamis Pharmaceuticals had a negative trailing twelve-month return on equity of 420.53% and a negative net margin of 556.71%. During the same period last year, the business earned ($0.16) EPS.

What other stocks do shareholders of Adamis Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Adamis Pharmaceuticals investors own include Trevena (TRVN), Amarin (AMRN), Sorrento Therapeutics (SRNE), Verastem (VSTM), Dynavax Technologies (DVAX), Novavax (NVAX), SCYNEXIS (SCYX), Synergy Pharmaceuticals (SGYP), Agile Therapeutics (AGRX) and OPKO Health (OPK).

What is Adamis Pharmaceuticals' stock symbol?

Adamis Pharmaceuticals trades on the NASDAQ under the ticker symbol "ADMP."

Who are Adamis Pharmaceuticals' major shareholders?

Adamis Pharmaceuticals' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Geode Capital Management LLC (0.88%), Simplex Trading LLC (0.00%), HighTower Advisors LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include David C Benedicto, David J Marguglio, Dennis J Phd Carlo, Karen K Daniels, Robert O Hopkins and Ronald B Moss.
View institutional ownership trends.

How do I buy shares of Adamis Pharmaceuticals?

Shares of ADMP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Adamis Pharmaceuticals' stock price today?

One share of ADMP stock can currently be purchased for approximately $0.12.

How much money does Adamis Pharmaceuticals make?

Adamis Pharmaceuticals (NASDAQ:ADMP) has a market capitalization of $17.85 million and generates $4.76 million in revenue each year.

How many employees does Adamis Pharmaceuticals have?

The company employs 116 workers across the globe.

How can I contact Adamis Pharmaceuticals?

Adamis Pharmaceuticals' mailing address is 11682 EL CAMINO REAL SUITE 300, SAN DIEGO CA, 92130. The official website for the company is www.adamispharmaceuticals.com. The specialty pharmaceutical company can be reached via phone at (858) 997-2400 or via email at mflather@adamispharma.com.

This page (NASDAQ:ADMP) was last updated on 3/25/2023 by MarketBeat.com Staff